Contec launches virtual training tool sensitive to social distancing
A web-based means of finding the cleaning products to meet the challenges posed by cleanroom operations.
The ongoing consequences of the novel coronavirus (COVID-19) now include the urgent call for social distancing (meeting postponement, limiting site visitors to facilities, etc.) Contec has, therefore, accelerated the launch of its online learning and training tool, VAL.
VAL (Virtual Assisted Learning) is a web-based means of allowing customer-partners to find the appropriate critical cleaning products to meet the challenges posed by their cleanroom operations by Grade/ISO Class. Moreover, each specific virtual 'environment' features numerous touch-points that highlight product solutions through clickable PDFs and videos which showcase best practice applications to clean and disinfect key equipment and/or surfaces.
“We understand and respect the steps our customers are taking to protect their employees and products,” says Matt Schiering, Chief Marketing Officer for Contec “Our digital and multimedia teams collaborated closely with product management and our customers to develop an educational portal that will assist users whether a rep is physically present or not. VAL works anywhere a customer wishes to access it – from home or work – on the device of their choice.”
VAL is more than a product selection tool; it also provides guidance, education and best practices to maintain the highest standards across a variety of critical cleaning environments. VAL covers more than two dozen touch-points, highlighting appropriate products for each specified area. VAL also features 25 distinct product recommendation PDFs, and provides 22 best-practice videos and eight custom illustrations for the US.
“The goal of VAL is to provide assistance to our customers whenever and wherever they need it,” shared Rick Harward, one of Contec’s cleanroom business managers. “In light of the current, evolving situation, we can’t be everywhere we’d like to be. But now, our service and expertise can be present even if we can’t be. Our entire salesforce will be available for any questions or to walk someone through VAL.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance